Healthcare of Ontario Pension Plan Trust Fund Buys Shares of 29,400 Caleres, Inc. (NYSE:CAL)

Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Caleres, Inc. (NYSE:CAL - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 29,400 shares of the textile maker's stock, valued at approximately $972,000. Healthcare of Ontario Pension Plan Trust Fund owned approximately 0.08% of Caleres at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. Louisiana State Employees Retirement System boosted its holdings in shares of Caleres by 2.4% in the 3rd quarter. Louisiana State Employees Retirement System now owns 17,000 shares of the textile maker's stock valued at $562,000 after buying an additional 400 shares in the last quarter. SummerHaven Investment Management LLC boosted its stake in Caleres by 1.4% in the second quarter. SummerHaven Investment Management LLC now owns 29,394 shares of the textile maker's stock valued at $988,000 after acquiring an additional 409 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in shares of Caleres by 3.2% during the third quarter. State of Alaska Department of Revenue now owns 20,047 shares of the textile maker's stock worth $662,000 after purchasing an additional 628 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in shares of Caleres by 4.8% during the second quarter. The Manufacturers Life Insurance Company now owns 16,743 shares of the textile maker's stock worth $563,000 after purchasing an additional 761 shares in the last quarter. Finally, Quest Partners LLC lifted its holdings in shares of Caleres by 6.6% in the 3rd quarter. Quest Partners LLC now owns 14,028 shares of the textile maker's stock valued at $464,000 after purchasing an additional 869 shares during the last quarter. Hedge funds and other institutional investors own 98.44% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on CAL. StockNews.com downgraded Caleres from a "buy" rating to a "hold" rating in a research note on Thursday, October 3rd. Loop Capital cut their target price on shares of Caleres from $45.00 to $30.00 and set a "hold" rating on the stock in a report on Friday, September 13th.

Caleres Trading Up 0.4 %

Shares of Caleres stock traded up $0.12 during trading hours on Tuesday, hitting $32.47. 434,178 shares of the company were exchanged, compared to its average volume of 536,021. The business has a 50-day moving average of $31.31 and a 200-day moving average of $34.34. Caleres, Inc. has a 1 year low of $27.67 and a 1 year high of $44.51. The stock has a market capitalization of $1.14 billion, a price-to-earnings ratio of 7.00 and a beta of 1.92.

Caleres (NYSE:CAL - Get Free Report) last posted its quarterly earnings results on Thursday, September 12th. The textile maker reported $0.85 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.22 by ($0.37). Caleres had a return on equity of 24.63% and a net margin of 5.84%. The firm had revenue of $683.30 million for the quarter, compared to analysts' expectations of $723.80 million. During the same period in the prior year, the company earned $0.98 earnings per share. The company's revenue for the quarter was down 1.8% on a year-over-year basis. As a group, research analysts anticipate that Caleres, Inc. will post 4.01 earnings per share for the current fiscal year.

Caleres Profile

Caleres, Inc engages in the retail and wholesale of footwear business in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr.